Stock search

Ticker or company name

Compare stocks

Market: US

  • CNCCentene Corporation
  • DXCMDexcom
  • RMDResMed

Add stock

Ticker or company

Summary

CNC
Centene Corporation
$74,77Up +4,91%
Year: Up +94%
72/100Ratio would consider buying
Open stock page
DXCM
Dexcom
$81,61Down −2,06%
Year: Up +40%
89/100Best scoreRatio would consider buying
Open stock page
RMD
ResMed
$238,19Down −0,56%
Year: Down −5%
83/100Ratio would consider buying
Open stock page

Verdict

DXCM has the best score (89). CNC grows revenue the fastest. CNC is the cheapest by forward P/E. CNC has the lowest debt load. RMD has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckCNC5 ✓ 3 — 1 ✕DXCM8 ✓ 0 — 1 ✕RMD6 ✓ 3 — 0 ✕
P/E vs its history24,231,421,3
P/E vs industry24,231,421,3
Forward P/E13,526,818,4
Revenue growth, YoY+9,7%+13,0%+9,0%
EPS growth, YoY—+41,1%+12,4%
Net margin0,7%19,4%27,8%
Net debt / EBITDA−3,6−0,6−0,4
Free cash flow$3,94 bn$1,10 bn$1,61 bn
Share count over a year+0,6%−5,9%−2,4%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterCNCTTMDXCMTTMRMDTTMIndustry medianTTM
P/E TTM ↓24,2Worst: 31,4Best: 21,325,1
Forward P/E ↓Best: 13,5Worst: 26,818,416,2
PEG ↓n/aBest: 1,4Worst: 1,82,2
P/S TTM ↓Best: 0,2Worst: 6,15,92,2
EV/EBITDA ↓Best: 13,5Worst: 21,016,717,3
P/FCF ↓Best: 4,0Worst: 28,321,419,5

Price, %

  • CNCn/a
  • DXCMn/a
  • RMDn/a

Returns

Best WorstNo mark — in between

PeriodCNCDXCMRMD
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

CNCDXCMRMD
Share of “buy”Worst: 48%Best: 89%52%
Beat the forecastBest: 4 of 4Worst: 3 of 4Best: 4 of 4
Average “surprise”Best: +63,6%Worst: +0,9%+3,1%
Insiders over 12 monthssales $14,6 msales $12,2 msales $20,2 m

Details are on each stock page.